DB06563ExperimentalProtein Based Therapies
Leconotide (development codes CNSB004 and AM336) is an omega-conotoxin peptide known for its analgesic properties, which work by blocking neuronal voltage-sensitive calcium channels. It was investigated as a potential treatment...
- Mechanism
- Curator reviewed
Pharmacologically active on Voltage-dependent N-type calcium channel subunit alpha-1B
- Primary indication
- Investigated for use/treatment in pain (acute or chronic).Curator reviewed
- Also known as
- LECONOTIDE · OMEGA-CONOPEPTIDE
- Code names
- AM336 · CNSB004
Resolves to
Compound
Targets
What you can answer from here — as of July 03, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with AM336, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account